We also found that increased expression of cardiomyopathy markers, natriuretic peptide A (Nppa) and natriuretic peptide B (Nppb) seen in vehicle-treated NSML mice were significantly inhibited in dasatinib-treated NSML mice (Fig. 4d, e). Here, NPPB is linked to cardiomyopathy.